IRF1 and acute myeloid leukemia: We also compared leukemic activated HSCs to their dormant counterparts (41), identifying TFs essential for hematopoiesis and AML progression, such as MYC (60), SIN3A (61), SAP30 (62) and IRF1 ((63) and Supplementary Figure S8C).